Christopher (Chris) Raphaely is the Co-chair of the Health Care & Life Sciences Practice Group at Cozen O’Connor, a full-service law firm with practices in litigation, business, and government relations. In his role, he provides transactional and regulatory counsel to various healthcare providers and investors.

With nearly three decades of experience in the healthcare industry, Chris specializes in mergers and acquisitions, payer negotiations, HIPAA compliance, and value-based payment arrangements. Before joining Cozen O’Connor, he served as Deputy General Counsel at Jefferson Health System, where he facilitated major transactions and led the system’s restructuring efforts.

Since the advent of the new presidential administration, the healthcare industry has experienced a period of intense disruption; regulatory overhauls, rising costs, and an influx of cutting-edge technology have created complexity for providers, investors, and entrepreneurs. At the center of it all are high-stakes transactions requiring legal precision and a strategic vision. How can leaders in this space make informed decisions and future-proof their deals in such a volatile environment?

Healthcare transaction attorney Chris Raphaely urges healthcare practices and providers to understand legal risks as well as the operational and regulatory contexts in which healthcare organizations operate. He advises aligning legal strategies with your business model, fostering collaborative negotiations, and staying abreast of changing regulations. Healthcare businesses should also prepare for potential financial disruptions caused by policy changes and emerging technologies.

In today’s Transaction Healthcare episode, Zak Eisenberg speaks with Christopher (Chris) Raphaely, Co-chair of the Health Care & Life Sciences Practice Group at Cozen O’Connor, about navigating the regulatory landscape to structure healthcare transactions. Chris shares insights on value-based care, Medicaid expansion, ACA subsidy shifts, and how to navigate C-suite dynamics.